Introduction {#s1}
============

Alcohol (ethanol, EtOH) consumption has profound effects on brain function and behavior (Olsen et al., [@B40]; Abrahao et al., [@B1]). Continued excessive EtOH consumption can lead to the development of dependence that is associated with withdrawal symptoms when alcohol consumption is ceased or substantially reduced. EtOH acts on GABA~A~ receptors (GABA~A~Rs) as a major pharmacological target in the brain (Rudolph et al., [@B48]; Olsen et al., [@B40]; Olsen and Sieghart, [@B42]). GABA~A~Rs are ligand-gated chloride channels assembled into heteropentamers, which mediate the majority of inhibitory neurotransmission in the brain (Mehta and Ticku, [@B34]; Rudolph et al., [@B48]). GABA~A~R function can be allosterically enhanced by EtOH (Wallner et al., [@B54]; Olsen et al., [@B40]), and chronic activation of GABA~A~Rs by EtOH produces plastic changes that may contribute to EtOH tolerance, dependence and withdrawal symptoms (Liang et al., [@B32]; Kumar et al., [@B26]). GABA~A~Rs composed of α1--3 and γ2 subunits largely localize at synaptic sites and participate in the phasic (synaptic) inhibitory control of neuronal activity, whereas α4--6 and δ subunits are predominantly expressed extrasynaptically and mediate tonic (extrasynaptic) inhibition (Farrant and Nusser, [@B16]; Glykys et al., [@B17]; Brickley and Mody, [@B6]). Different GABA~A~R subunits have distinct localization, physiological and pharmacological properties, which account for variable sensitivity to GABA~A~R modulators and subsequent behavioral consequences (Puia et al., [@B46]; Whiting et al., [@B59]; Olsen and Sieghart, [@B42]).

Previous studies have elucidated that synaptic and extrasynaptic GABA~A~R subtypes are differentially modulated by EtOH (Sundstrom-Poromaa et al., [@B53]; Wallner et al., [@B54]; Wei et al., [@B55]). Extrasynaptic δ subunit-containing GABA~A~Rs (δ-GABA~A~Rs) are abundantly expressed in the hippocampus (Sperk et al., [@B52]; Peng et al., [@B44]) with unique properties such as high affinity for GABA, slow desensitization kinetics, benzodiazepine insensitivity and high sensitivity for EtOH (Sundstrom-Poromaa et al., [@B53]; Wallner et al., [@B54]; Wei et al., [@B56], [@B55]; Mody and Pearce, [@B37]; Hanchar et al., [@B20]; Liang et al., [@B31]). GABA~A~R-δ subunits are important targets for EtOH (Olsen and Liang, [@B41]). δ deficient (δ^−/−^) mice show defects in their behavioral responses to EtOH, with reduced EtOH consumption, attenuated withdrawal from chronic EtOH exposure, and reduced anticonvulsant effects of EtOH (Mihalek et al., [@B36]); Chronic intermittent EtOH (CIE) treatment and withdrawal in rats results in decreased EtOH-enhanced δ-GABA~A~R-mediated tonic inhibitory current (*I*~tonic~) correlated to down-regulated δ subunit (Cagetti et al., [@B8]; Liang et al., [@B30], [@B32]). Furthermore, a single intoxicating dose of EtOH administered by gavage is able to induce many of the same, but transient changes in behavior, GABA~A~R subunit composition, and hippocampal neuron pharmacology seen in CIE (Liang et al., [@B31]; Olsen and Spigelman, [@B43]; Olsen and Liang, [@B41]). This indicates that the plasticity induced by a single EtOH is likely to be helpful in figuring out what plasticity induced by chronic and/or repeated EtOH administration can be dependence-inducing.

The rapid (within 1-h withdrawal) down-regulation of δ-GABA~A~R function and cell-surface subunit level by a single EtOH primarily results from increased δ-GABA~A~R endocytosis rather than decreased surface insertion (Shen et al., [@B50]; Gonzalez et al., [@B18]). Phosphorylation regulation of GABA~A~Rs has been suggested in EtOH-mediated GABA~A~R plasticity (Kumar et al., [@B26]; Nakamura et al., [@B38]) for both synaptic γ2-GABA~A~Rs (Qi et al., [@B47]) and extrasynaptic δ-GABA~A~Rs (Choi et al., [@B14]). As a critical regulator of protein phosphorylation, protein kinase C (PKC) modulates the surface expression of both recombinant and native GABA~A~Rs in cultured neurons (Chapell et al., [@B13]) by endocytosis into clathrin-coated vesicles (CCVs; Kittler et al., [@B25]). Moreover, PKC plays important roles in facilitating EtOH regulation of GABA~A~Rs (Kumar et al., [@B28], [@B27]; Werner et al., [@B57]), and in regulation of EtOH-mediated behavioral effects (Harris et al., [@B21]; Hodge et al., [@B22]; Choi et al., [@B14]). Previous studies in transgenic or knockout manipulation of PKC isoforms demonstrate that PKC isoforms may participate in EtOH-mediated GABA~A~R plasticity and behavioral effects: PKCε mutant mice are more sensitive to short-term EtOH exposure, whereas the deletion of PKCε attenuates EtOH withdrawal-associated seizures in mice (Olive et al., [@B39]); PKCγ knockout mice are resistant to the short-term intoxicating effects of EtOH and fail to develop EtOH tolerance (Harris et al., [@B21]; Bowers et al., [@B4]; Bowers and Wehner, [@B5]); PKCδ knockout mice have shown diminished acute responses to EtOH (Choi et al., [@B14]). However, whether PKC isoforms modulate the effects of a single EtOH withdrawal on δ-GABA~A~Rs remains to be investigated.

Here we show that PKC inhibition prevents the decreases in *I*~tonic~ amplitude and responsiveness to acute EtOH as well as the reduction in extrasynaptic δ subunit abundance induced by a single EtOH withdrawal. Moreover, EtOH withdrawal selectively increases PKCδ level in neurons, whereas PKCδ inhibition specifically blocked the EtOH withdrawal-induced alterations in protein level of δ subunits and δ-GABA~A~R function. Together, our findings highlight the importance of PKCδ in a single EtOH withdrawal-regulation of extrasynaptic δ-GABA~A~Rs.

Materials and Methods {#s2}
=====================

All procedures were carried out in accordance with the recommendations of National Institutes of Health Guidelines for the Care and Use of Laboratory Animals and were approved by the Animal Advisory Committee at Zhejiang University. For all materials involving biohazards, biological select agents, toxins and restricted materials or reagents used in the study, the standard bio-safety procedures were approved by the Division of Laboratory and Equipment Management at Zhejiang University.

Primary Hippocampal Neuron Culture {#s2-1}
----------------------------------

The protocol was approved by the Animal Advisory Committee at Zhejiang University. Hippocampal neurons from embryonic 18 (E18) Sprague-Dawley rats were prepared as described previously (Shen et al., [@B50]). Briefly, embryos were removed from pregnant rats anesthetized with isoflurane and euthanized by decapitation. Hippocampi were dissected and placed in Ca^2+^- and Mg^2+^-free N-2-hydroxy-ethylpiperazine-N-2-ethanesulfonic acid (HEPES)-buffered Hank's balanced salt solution (HBSS; pH 7.45), followed by a digestion with 0.25% w/v trypsin. After trituration through a Pasteur pipette, neurons were centrifuged (1000 *g* for 5 min) and resuspended in Neurobasal medium containing 2% B27 serum-free supplement, 1% v/v penicillin/streptomycin (P/S), 0.5 mM glutamine, and 10 μM glutamate (Sigma-Aldrich). Dissociated cells were then plated at a density of 0.03 × 10^6^ cells/cm^2^ onto 12-mm-diameter round coverslips in 24-well plates (Corning Costar^°ledR^, for recordings) and glass bottom confocal dishes (NEST Biotechnology, for live-cell imaging), as well as at a density of 0.05 × 10^6^ cells/cm^2^ in 150-mm-diameter dishes (for Western blots) pre-coated with poly-D-lysine (PDL, 50 μg/ml; Sigma-Aldrich). Cultures were kept at 37°C in a 5% v/v CO~2~ humidified incubator. Thereafter, one third to half of the medium was replaced twice a week with Neurobasal culture medium containing 2% B27 supplement, and 0.5 mM glutamine. All reagents were purchased from Thermo Fisher Scientific unless otherwise specified.

EtOH and Drug Treatment {#s2-2}
-----------------------

Cultured neurons at 13-14 days *in vitro* (DIV13-14; DIV9--10 for transfected-neurons) were used for EtOH and drug treatments. Before experiments, half of the culture medium was replaced with Neurobasal culture medium containing 120 mM EtOH (final concentration was 60 mM) for 30 min, and then the entire medium was replaced by half fresh Neurobasal culture medium plus half original medium. Control neurons were treated with corresponding vehicle using the same procedure as EtOH exposure and withdrawal. The test compounds including okadaic acid (OA, a phosphatase blocker, 100 nM); phorbol 12,13-dibutyrate (PDBu, a PKC activator, 100 nM) and forskolin (a PKA activator, 10 μM) were added in the culture medium for 30 min immediately before experiments, whereas the test compounds including chelerythrine chloride (Che, a PKC inhibitor, 10 μM), H-89 dihydrochloride hydrate (H89, a PKA inhibitor, 20 μM), and a selective PKCδ inhibitor Rottlerin (Enzo Life Science, 10 μM), and a selective PKCε inhibitor peptide myristoylated-EAVSLKPT (EAV; peptide sequence: H-Glu-Ala-Val-Ser-Leu-Lys-Pro-Thr-OH, 10 μM, Santa Cruz) were added in the culture medium at 10 min (30 min for EAV) before EtOH or vehicle exposure, and were then also included during EtOH exposure and withdrawal periods. All reagents were purchased from Sigma-Aldrich unless otherwise specified.

Plasmids, siRNAs and Transfection {#s2-3}
---------------------------------

Rat GABA~A~R α1 and δ subunit cDNAs were obtained from M. Wallner (University of California, Los Angeles, CA, USA; Wallner et al., [@B54]). The ORFs and part of the 3′ UTRs of GABA~A~R α1 and δ subunits were amplified by PCR and cloned into a vector pcDNA3.1 with CMV promoter. The primers used for GABA~A~R-δ subunit were 5′-CCCAAGCTTATGGACGCGCCC-3′ (a HindIII site at the 5′ end) and 5′-CGGGATCCCATGGCGTATGCCG-3′ (a BamHI site at the 3′ end). The primers used for GABA~A~R α1 subunit were 5′-TAGCTAGCTATGAGGAAAAGTCCAGGTCTG-3′ (a Nhe1 site at the 5′ end) and 5′-GGAATTCTTGATGTGGTGT GGGGGCTTTTAG-3′ primers (an EcoRI site at the 3′ end). The PCR product was separated by electrophoresis and then purified by gel extraction kit (Simgen). pcDNA3.1-GABA~A~R-δ and pcDNA3.1-GABA~A~R-α1 were constructed by using T~4~ DNA ligase (BioLabs) to ligate the isolated PCR product with the vector. To obtain the recombinant plasmid pcDNA3.1-GABA~A~R-δ-mCherry, the fluorescent protein coding sequence was amplified using 5′-CCCAAGCTTATGGACGCGCCC-3′ and 5′-CGGGATCCCATGGCGTATGCCG-3′ primers by PCR, and then inserted into the BamHI site at the C-terminus of pcDNA3.1-GABA~A~R-δ. For construction of the recombinant pcDNA3.1-GABA~A~R-α1-EGFP, EGFP coding sequence was amplified using 5′-CGGG ATCCATGGTGAGCAAGGGCGAGG-3′ and 5′-CGGGAT CCTCACTTGTACAGCTCGTCC-3′ primers, and then inserted into the BamHI site at the C-terminal of pcDNA3.1-GABA~A~R-α1. pcDNA3.1-mCherry and pcDNA3.1-EGFP were used as the control plasmids. All primers were purchased from Thermo Fisher Scientific. All plasmids were sequenced to ensure correct reading frame, orientation and sequence.

Two different siRNA sequence pairs from Thermo Fisher Scientific were used simultaneously to selectively inhibit PKCγ (GenBank accession number: NM_012628.1). The sequences are as follows: pair 1, 5′-GGAGGAGGGCGAGUAUUACAAUGUA-3′ and 5′-UACAUUGUAAUACUCGCCCUCCUCC-3′; pair 2, 5′-UCGGCAUGUGUAAAGAGAAUGUCUU-3′ and 5′-AAGACAUUCUCUUUACACAUGCCGA-3′. Two different siRNA sequence pairs from GenePharma were used simultaneously to selectively inhibit PKCδ (GenBank accession number: NM_133307.1). The sequences are as follows: pair 1, 5′-GCAUCUCCUUCAAUUCCUATT-3′ and 5′-UAGGAAUUGAAGGAGAUGCTT-3′; pair 2, 5′-GCAAGAAGAACAACGGCAATT-3′ and 5′-UUGCCGUUGUUCUUCUUGCTT-3′. Scrambled siRNAs (5′-UUCUCCGAAGGUGUCACGUTT-3′ and 5′-ACGUGACACGUUCGGAGAATT-3′) were used as the negative controls.

Neurons at DIV5 were transfected with purified plasmids or siRNAs using lipofectamine 3000 in an Opti-MEM medium according to the vendor's protocol. Briefly, neurons in 6-well plates were incubated with the plasmid DNA (2.5 μg/well) or siRNA (0.1 nM, 5 μl/well) combined with Lipofectamine 3000 (3.75 μl). Each transfection was done in triplicate. The media containing complexes were removed at 3.5--4 h after transfection, and the cells were rinsed twice with Opti-MEM medium and then refilled with half fresh Neurobasal culture medium plus half original medium. The siRNA transfected-neurons at DIV9--10 (for confocal microscopy) and the plasmid transfected-neurons at DIV13--14 (for biochemical analyses) were used. All reagents were purchased from Thermo Fisher Scientific unless otherwise specified.

Whole-Cell Patch-Clamp Recording {#s2-4}
--------------------------------

Immediately before electrophysiological recording, neurons at DIV13--14 were transferred to a perfusion chamber and visualized with an inverted microscope (IX51; Olympus). Whole-cell patch-clamp recordings were performed in the voltage-clamp mode in putative pyramidal neurons (with an oval or pyramidal bright soma) at room temperature (22--23°C) at a holding potential of −70 mV. For GABA~A~R-mediated mIPSC recordings, neurons were perfused with a bath solution containing (in mM): 137 NaCl, 5 KCl, 2 CaCl~2~, 1 MgCl~2~, 20 Glucose and 10 HEPES (pH 7.40, 310--320 mOsm). Glass pipettes were filled with internal solution containing (in mM): 137 CsCl, 2 MgCl~2~, 1 CaCl~2~, 11 EGTA, 10 HEPES and 3 ATP (290--300 mOsm, pH adjusted to 7.30 with CsOH), with an input resistance of 4--7 MΩ. mIPSCs were pharmacologically isolated by adding tetrodotoxin (TTX, 0.5 μM, Ascent Scientific), APV (40 μM, Ascent Scientific), CNQX (10 μM, Ascent Scientific) and CGP54626 (1 μM, Tocris Bioscience) to the bath solution. Final concentrations of dimethyl sulfoxide (DMSO) did not exceed 0.01% in the recording chamber. All reagents were from Sigma-Aldrich unless specified otherwise. All functional recordings in drug-exposed neurons were carried out between 20 min and 40 min of drug incubation, and recordings for EtOH-withdrawn neurons were performed between 20 min and 40 min after EtOH withdrawal.

Recordings were amplified using an Axopatch 200B amplifier (Molecular Devices). Series resistance was normally less than 20 MΩ and recordings exceeding 20% change in series resistance were terminated and discarded. Electrophysiological recordings were filtered at 2.0 kHz and digitized at 50 kHz. Individual events were counted and analyzed with MiniAnalysis (Synaptosoft). For kinetic analysis, only single-event mIPSCs with a stable baseline, sharp rising phase (10%--90% rise time), and exponential decay were chosen during visual inspection of the recording traces. Double- and multiple-peak mIPSCs were excluded. The *I*~tonic~ magnitudes were obtained from the averaged baseline current of a given recording period. The amplitude of the *I*~tonic~ was calculated by the outward shift of the baseline holding currents after the application of bicuculline (10 μM), a competitive inhibitor of GABA~A~Rs, which can diminish both synaptic and *I*~tonic~ magnitude (Olsen and Sieghart, [@B42]; Shen et al., [@B50]). Only current recordings that exhibited a stable baseline were included in the analysis.

Biotinylation Assay for Cell-Surface Protein of GABA~A~R-δ Subunits {#s2-5}
-------------------------------------------------------------------

Cultured neurons at DIV13--14 were placed on ice and rinsed twice with ice-cold phosphate-buffered saline (PBS). The neurons were then incubated for 20 min on ice with PBS containing 1 mg/ml sulfo-NHS-LC-biotin (ProteoChem). After rinsing with Tris-buffered saline (TBS) to quench the biotin reaction, neurons were lysed in 150 μl of RIPA buffer \[1% Triton X-100, 0.1% sodium dodecyl sulfate (SDS), 150 mM NaCl, 2 mM EDTA, 50 mM NaF, 10 mM sodium pyrophosphate, 1.0 mM Na~3~VO~4~, 1.0 mM PMSF, and a complete protease inhibitor cocktail (Roche)\]. The homogenates were centrifuged for 14,000 *g* × 15 min at 4°C. An aliquot (10%) of the supernatant was removed to measure β-actin. The remaining supernatant was incubated with 60 μl of 50% neutravidin agarose (Pierce) for 4 h at 4°C and washed four times with the lysis buffer. Agarose-bound proteins were taken up in 40 μl of SDS sample buffer and boiled (Shen et al., [@B50]).

Western Blotting {#s2-6}
----------------

Cell-surface protein levels of GABA~A~R-δ subunits and total protein levels of PKC isoforms were measured. Cultured neurons at DIV13--14 were washed twice with ice-cold PBS after the medium was carefully aspirated, and then were collected on ice with ice-cold RIPA buffer mentioned above in "Biotinylation Assay" section. The lysate was then centrifuged at 14,000 *g* × 15 min at 4°C and the supernatant collected for Western blot analysis. Protein concentrations were determined using a Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific) and the samples were stored at −20°C. Ten percentage SDS-PAGE was used to separate protein samples. After electrophoresis, the gels were transferred onto polyvinylidene fluoride (PVDF) membranes (Merck Millipore) using a constant voltage of 300 mA for 90 min. The membranes were then blocked in 5% milk in TBST (25 mM Tris-HCl, 150 mM NaCl and 0.1% Tween 20, pH 7.4) for 1.5 h at room temperature on a shaker, and incubated with the primary antibody overnight at 4°C. Primary antibodies were prepared with 5% milk in TBST \[rabbit anti-GABA~A~R-δ (gift from Dr. W. Sieghart, Medical University Vienna, Austria), mouse anti-PKCδ (BD Biosciences), mouse anti-PKCε (BD Biosciences), rabbit anti-PKCγ (Abcam), and mouse anti-β-actin (Sigma-Aldrich)\]. Next, the membranes were rinsed three times in TBST for 10 min each before incubation with an anti-mouse or anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibody (Thermo Fisher Scientific) for 1 h at room temperature. After being washed in TBST five times for 10 min each at room temperature, protein bands were visualized using ECL or ECL-Plus Western blotting detection reagents (Pierce). Quantification of the intensity of the protein bands was performed using the NIH ImageJ software. Surface protein amount was calculated by the optical density of each cell-surface subunit signal divided by optical density of the corresponding β-actin signal of the total cell lysate (% of β-actin) and compared to control that is set to 100% (Shen et al., [@B51]).

Confocal Microscopy {#s2-7}
-------------------

Transfected-neurons at DIV9--10 were used for time-lapse live-cell imaging. The neurons in confocal dishes were perfused with bath solution containing (in mM): 145 NaCl, 5 KCl, 2 CaCl~2~, 2 MgCl~2~, 10 Glucose and 10 HEPES (pH 7.40, 290--310 mOsm) at 35°C. After baseline data (F~0~) were taken, the control bath solution was changed to bath solution containing 60 mM EtOH or drugs to record treated data (F). Then EtOH was washed out by normal culture medium, followed by another image taken at 30 min after withdrawal (F). The images were acquired by a Nikon A1 laser-scanning confocal microscope under a fixed set of settings. Images were viewed through a 60× oil-immersion objective (numerical aperture 1.4) and taken at 1024 × 1024 pixels resolution. The gain, threshold and offset levels were set equal during individual experiments (488 nm: gain, 7.00, HV, 50, offset, 0; 561 nm: gain, 1.70, HV 25, offset, 0). Pictures were analyzed by MetaMorph as previously described (Shen et al., [@B51]). Images were initially acquired as 12-bit grayscale and were prepared for presentation using Adobe Photoshop (Adobe Systems). The relative fluorescent signals expressed in arbitrary units (F/F~0~) were analyzed for individual cells using MetaMorph with a fixed set of parameters. All image analyses were done blind to the experimental condition. The numbers (n) in figure legends represent cell numbers from three independent cultures.

Statistics {#s2-8}
----------

SigmaPlot, SigmaStat (Systat Software, Inc.) and Prism (GraphPad Software) were used for data display and statistical analysis. Significance is reported as *p* \< 0.05, and data are expressed as mean ± SEM. Student *t* test, one-way analysis of variance (ANOVA) followed by a *post hoc* multiple comparison analysis based on the Dunnett's method, or two-way ANOVA followed by a *post hoc* multiple comparison analysis based on the Holm-Sidak method were used to determine significant levels between treatments and controls.

Results {#s3}
=======

Protein Phosphorylation Contributed to the Down-Regulation of Extrasynaptic GABA~A~R-Mediated *I*~tonic~ by a Single EtOH Withdrawal {#s3-1}
------------------------------------------------------------------------------------------------------------------------------------

We first measured the miniature inhibitory postsynaptic currents (mIPSCs) and baseline tonic activity in cultured hippocampal neurons at DIV14 with 30-min vehicle (Ctrl) or 60 mM EtOH exposure. The concentration of 60 mM EtOH used to treat cultured neurons was chosen as previously reported (Shen et al., [@B50]) to match blood levels measured in adult rats after intoxication with gavage of 5 g/kg, which induced substantial plasticity in GABA~A~Rs and drug tolerance (Liang et al., [@B31]). EtOH exposure for 30 min greatly potentiated *I*~tonic~ amplitude (*t* test; *t* = −8.662, *p* \< 0.001; Figures [1A,B](#F1){ref-type="fig"}), with no effect on either mIPSC area (Figures [1A,C](#F1){ref-type="fig"}) or frequency (Figures [1A,D](#F1){ref-type="fig"}). However, 30-min withdrawal from a single EtOH exposure (E/W) induced a significant reduction in *I*~tonic~ amplitude (one-way ANOVA; *F*~(2,33)~ = 84.586, *p* \< 0.001 vs. Ctrl group; Figures [1E,F](#F1){ref-type="fig"}). Virtually no change in either mIPSC area (Figures [1E,G](#F1){ref-type="fig"}) or frequency (Figures [1E,H](#F1){ref-type="fig"}) was observed in E/W-neurons compared with Ctrl group. The finding indicates that a single EtOH withdrawal, but not EtOH exposure, reduces extrasynaptic GABA~A~R function in neurons. To determine whether protein phosphorylation plays a role in a single EtOH withdrawal regulation of GABA~A~Rs, we also examined *I*~tonic~ amplitude and mIPSCs in neurons treated with a phosphatase inhibitor OA. Similar results were observed in OA-treated (100 nM, 30 min) neurons in the absence of EtOH (one-way ANOVA; *F*~(2,33)~ = 84.586, *p* \< 0.001 vs. Ctrl group; Figures [1E--H](#F1){ref-type="fig"}) compared with the neurons in E/W group.

![Okadaic acid (OA) mimics a single ethanol (EtOH) withdrawal-induced decreases in extrasynaptic GABA~A~R-mediated tonic current (*I*~tonic~) and *I*~tonic~ responsiveness to acute EtOH in cultured hippocampal neurons. Neurons were whole-cell voltage-clamped at −70 mV (holding potential, *I*~hold~). **(A)** Left: sample traces of individual recordings from neurons during 30-min vehicle (Ctrl) or 60 mM EtOH exposure (EtOH). Right: averaged miniature inhibitory postsynaptic currents (mIPSCs). The *I*~tonic~ amplitude is measured as currents at the experimental conditions vs. the mean current following bicuculline (Bic, 10 μM) application (dotted lines indicate *I*~hold~: basal, light-gray line commencing at left margin; Bic application, and light-gray line commencing near far right end). **(B--D)** Changes in *I*~tonic~ amplitude **(B)**, total chargetransfer of mIPSCs (mIPSC area, **C**) and mIPSC frequency **(D)** recorded in neurons from Ctrl and EtOH groups as shown in **(A)**. **(E)** Left: sample traces of individual recordings from neurons at 30 min after withdrawal from Ctrl and EtOH (60 mM for 30 min, E/W) as well as during 30-min OA (100 nM, OA) exposure. Right: averaged mIPSCs. **(F--H)** Changes in *I*~tonic~ amplitude **(F)**, mIPSC area **(G)** and frequency **(H)** recorded in neurons from Ctrl, E/W and OA groups as shown in **(E)**. **(I)** Sample traces of individual recordings from Ctrl-, E/W- and OA-treated neurons. The *I*~hold~ after acute EtOH application is indicated by light-gray dotted lines (middle line commencing near far right end). **(J)** The effects of EtOH on *I*~tonic~ amplitude from the same recordings as shown in **(I)**. *n* = 10--13 per group. ^\#^*p* \< 0.001 vs. Ctrl group (*t* test in **B** and one-way ANOVA with *post hoc* Dunnett's test in **F**); ^†^*p* \< 0.001 vs. the pre-EtOH baseline value, \**p* \< 0.001 vs. Ctrl group (two-way ANOVA with *post hoc* Holm-Sidak test).](fnmol-11-00141-g0001){#F1}

Since extrasynaptic δ-GABA~A~Rs are thought to be particularly and highly sensitive for EtOH (Olsen et al., [@B40]; Shen et al., [@B50]), next we tested the *I*~tonic~ responsiveness to acute EtOH in Ctrl-, E/W- and OA-neurons. Approximately 80% of the control neurons recorded (*n* = 13) showed *I*~tonic~ potentiation by acute EtOH (60 mM; two-way ANOVA; *F*~(1,66)~ = 32.589, *p* \< 0.001 vs. pre-EtOH baseline value; Figures [1I,J](#F1){ref-type="fig"}), consistent with our previous study (Shen et al., [@B50]). However, 30-min withdrawal from both a single EtOH and OA exposure resulted in *I*~tonic~ tolerance to acute EtOH (two-way ANOVA; *F*~(2,66)~ = 150.933, *p* \< 0.001 vs. Ctrl group; *F*~(2,66)~ = 15.826, *p* \< 0.001, significant interaction effect between groups and E/W treatments; Figures [1I,J](#F1){ref-type="fig"}), suggesting that protein phosphorylation contributes to the rapid down-regulation of extrasynaptic δ-GABA~A~R sensitivity to acute EtOH by a single EtOH withdrawal.

PKC Inhibition Prevented the Decrease in *I*~tonic~ Amplitude and Acute EtOH Sensitivity Induced by a Single EtOH Withdrawal {#s3-2}
----------------------------------------------------------------------------------------------------------------------------

It has been reported that PKC and protein kinase A (PKA) play important but differential roles in facilitating GABA~A~Rs after EtOH exposure (Kumar et al., [@B28], [@B27]; Werner et al., [@B57]; Bohnsack et al., [@B3]; Carlson et al., [@B10],[@B11]). Therefore, we next examined the impact of inhibiting PKC or PKA in the presence of EtOH to determine whether PKC or PKA might be involved in the effects of a single EtOH withdrawal on extrasynaptic δ-GABA~A~Rs. Inhibiting PKC by chelerythrine chloride (Che, 10 μM) in the presence of EtOH prevented a single EtOH withdrawal-induced decreases in *I*~tonic~ amplitude and acute EtOH sensitivity (two-way ANOVA; *F*~(5,132)~ = 104.6, *p* \< 0.001 vs. Ctrl group; *F*~(1,132)~ = 95.471, *p* \< 0.001 vs. pre-EtOH baseline value; *F*~(5,132)~ = 11.608, *p* \< 0.001, significant interaction effect between groups and E/W treatments; Figure [2](#F2){ref-type="fig"}). However, PKA inhibition by H89 (20 μM) had no effect on EtOH withdrawal-regulation of *I*~tonic~ amplitude and acute EtOH tolerance. Che or H89 alone had no effect on either *I*~tonic~ amplitude or acute EtOH responsiveness (Table [1](#T1){ref-type="table"}). The results indicated that a single EtOH withdrawal-induced *I*~tonic~ reduction and acute EtOH tolerance were prevented by PKC but not PKA inhibition. We then used the PKC activator PDBu (100 nM) to determine whether PKC activation has similar activity in our system. PDBu exposure in the absence of EtOH resulted in smaller but significant *I*~tonic~ reduction and acute EtOH tolerance, consistent with the results observed in the OA group. However, PKA activation by forskolin (10 μM) in the absence of EtOH had no effect on either *I*~tonic~ amplitude or acute EtOH responsiveness. No alteration in mIPSC area or frequency was observed in the experiments (Table [1](#T1){ref-type="table"}). Taken together, these results suggest that PKC but not PKA activation contributes to the rapid down-regulation of extrasynaptic δ-GABA~A~Rs by a single EtOH withdrawal.

![Protein kinase C (PKC) inhibition prevents a single EtOH withdrawal-induced decrease in *I*~tonic~ amplitude and acute EtOH responsiveness. **(A)** Sample traces of individual recordings from neurons obtained at 30 min after withdrawal from Ctrl, EtOH (E/W), chelerythrine chloride (Che, 10 μM) plus EtOH (Che+E/W), and H89 (20 μM) plus EtOH (H89+E/W) exposure. **(B)** Changes in *I*~tonic~ amplitude and acute EtOH responsiveness in neurons from Ctrl, E/W, Che+E/W, phorbol 12, 13-dibutyrate (PDBu; 100 nM, 30 min), H89+E/W, and forskolin (10 μM, 30 min) groups. *n* = 10--14 per group. ^†^*p* \< 0.001 vs. the pre-EtOH baseline value, \**p* \< 0.001 vs. Ctrl group (two-way analysis of variance (ANOVA) with *post hoc* Holm-Sidak test).](fnmol-11-00141-g0002){#F2}

###### 

Effects of ethanol (EtOH) and drug treatments on *I*~tonic~ amplitude, mIPSC area and mIPSC frequency.

                    *I*~tonic~ amplitude (pA)   mIPSC area (fC)   mIPSC Frequency (Hz)                                  
  ----------------- --------------------------- ----------------- ---------------------- ---------------- ------------- -------------
  Ctrl              22.2 ± 0.9                  36.6 ± 3.0^†^     2995.3 ± 232.5         2705.1 ± 193.7   2.47 ± 0.18   2.54 ± 0.21
  E/W               8.5 ± 0.5                   9.9 ± 0.7\*       2615.5 ± 276.5         2648.3 ± 211.7   2.56 ± 0.23   2.65 ± 0.21
  Che + E/W         18.9 ± 1.1                  31.8 ± 1.7^†^     2895.7 ± 254.6         2791.6 ± 305.9   2.36 ± 0.16   2.45 ± 0.15
  Che               20.8 ± 1.5                  33.3 ± 2.2^†^     2811.4 ± 297.9         2855.4 ± 224.1   2.49 ± 0.26   2.62 ± 0.24
  PDBu + E/W        6.1 ± 0.6                   6.9 ± 0.6\*       2508.3 ± 226.2         2811.1 ± 297.9   2.28 ± 0.23   2.32 ± 0.23
  PDBu              13.1 ± 0.7                  16.1 ± 0.8\*      2805.8 ± 258.2         2592.9 ± 232.5   2.45 ± 0.20   2.57 ± 0.18
  H89 + E/W         6.9 ± 0.5                   7.6 ± 0.6\*       2682.0 ± 312.7         2772.3 ± 148.4   2.32 ± 0.16   2.43 ± 0.20
  H89               20.0 ± 0.7                  31.3 ± 1.8^†^     2888.2 ± 208.5         2801.8 ± 225.0   2.60 ± 0.12   2.67 ± 0.17
  Forskolin + E/W   7.0 ± 0.8                   8.2 ± 0.9\*       2662.5 ± 200.7         2504.7 ± 185.3   2.23 ± 0.18   2.35 ± 0.17
  Forskolin         20.9 ± 1.2                  34.1 ± 1.7^†^     2516.8 ± 150.2         2690.0 ± 219.5   2.16 ± 0.24   2.15 ± 0.17

*n = 11--14 per group. ^†^p \< 0.001 vs. the pre-EtOH baseline value, \*p \< 0.001 vs. Ctrl group (two-way ANOVA with post hoc Holm-Sidak test)*.

PKC Inhibition Prevented the Reduction in Cell-Surface Level of Extrasynaptic δ Subunits by a Single EtOH Withdrawal {#s3-3}
--------------------------------------------------------------------------------------------------------------------

Because extrasynaptic sensitivity to EtOH is correlated to δ subunit expression in cultured neurons (Shen et al., [@B50]), it is possible that the cell-surface level of δ subunits may be also altered in our cultures. Biotinylation assay and western blot analysis revealed that a single EtOH withdrawal notably reduced the cell-surface level of δ content (one-way ANOVA; *F*~(3,18)~ = 7.428, *p* = 0.003; Figure [3A](#F3){ref-type="fig"}), whereas 30-min EtOH exposure had no effect (data not shown). These results illustrated that an EtOH withdrawal reduced both δ-GABA~A~R function and δ subunit level in hippocampal neurons as previously reported (Shen et al., [@B50]). Withdrawal from EtOH exposure in the presence of Che prevented the reduction in cell-surface δ abundance (*p* = 0.932, Che+E/W vs. Ctrl group; *p* = 0.016, Che+E/W vs. E/W group), while Che alone had no effect (*p* = 0.999, Che vs. Ctrl group; *p* = 0.009, Che vs. E/W group; Figure [3A](#F3){ref-type="fig"}). We then measured the fluorescence intensity of recombinant δ subunit in neurons transfected with the pcDNA3.1-GABA~A~R-δ-mCherry plasmid or control plasmid by time-lapse live-cell imaging. A single EtOH withdrawal, but not exposure, reduced the fluorescent intensity of recombinant δ subunits (two-way ANOVA; *F*~(2,231)~ = 3.888, *p* = 0.022 vs. pre-drug baseline value; Figure [3B](#F3){ref-type="fig"}). No alteration of recombinant δ intensity in vehicle group was observed during the whole period. PKC inhibition by Che blocked EtOH withdrawal-induced reduction in recombinant δ intensity (two-way ANOVA; *F*~(3,231)~ = 2.675, *p* = 0.048 vs. vehicle group; *F*~(6,231)~ = 2.229, *p* = 0.041, significant interaction effect between groups and drug treatments; Figure [3B](#F3){ref-type="fig"}). Together, these data indicate that the down-regulation of extrasynaptic δ-GABA~A~Rs by a single EtOH withdrawal is most likely mediated by PKC activation.

![PKC inhibition prevents a single EtOH withdrawal-induced reduction in cell-surface level of native GABA~A~R-δ subunits and total protein level of recombinant δ subunits. **(A)** Representative western blots (top panels) and corresponding quantification (lower panel) of the biotinylation assay for cell-surface GABA~A~R-δ level in neurons from Ctrl, E/W, Che+E/W, and Che groups. β-actin of total cell lysate was used as the loading control. *n* = 4--5 per group. **(B)** Representative time-lapse live-cell images of pcDNA3.1-GABA~A~R-δ-mCherry transfected-neurons from EtOH and Che+EtOH treatments (top panels) and corresponding quantification of changes in recombinant δ subunit intensity in neurons from vehicle, EtOH, Che+EtOH, and Che treatments, respectively (lower panel). **(C)** Representative time-lapse live-cell images of pcDNA3.1-GABA~A~R-α1-EGFP transfected-neurons from EtOH and Che+EtOH treatments (top panels) and corresponding quantification of recombinant α1 subunit intensity in neurons from vehicle, EtOH, Che+EtOH, and Che treatments, respectively (lower panel). Scale bars = 10 μm. *n* = 19--21 per group. \**p* \< 0.05, ^\*\*^*p* \< 0.01 (one-way ANOVA with *post hoc* Dunnett's test); ^†^*p* \< 0.05 vs. the pre-drug baseline value, ^\#^*p* \< 0.05 vs. vehicle group (two-way ANOVA with *post hoc* Holm-Sidak test).](fnmol-11-00141-g0003){#F3}

Since typical synaptic GABA~A~R-α1 subunits (Rudolph et al., [@B48]) have reported to be down-regulated by EtOH (Liang et al., [@B31]; Kumar et al., [@B26]), we then determined the fluorescence intensity of recombinant α1 subunits in neurons transfected with the pcDNA3.1-GABA~A~R-α1-EGFP plasmid. No alteration in recombinant α1 intensity was found in neurons treated with EtOH exposure and withdrawal, Che co-exposure with EtOH and withdrawal or Che alone (Figure [3C](#F3){ref-type="fig"}), consistent with previously reported that the regulation of synaptic GABA~A~R-α1 subunits by a single EtOH withdrawal does not occur at early time point (within 1 h) after withdrawal (Shen et al., [@B50]). Meanwhile, PKC activation might not be involved in the regulation of α1 subunits by short-term (30 min) EtOH exposure or withdrawal.

PKCδ Inhibition Prevented the Reductions in Cell-Surface Protein Level of δ Subunits and δ-GABA~A~R Function Induced by a Single EtOH Withdrawal {#s3-4}
------------------------------------------------------------------------------------------------------------------------------------------------

Since the effects of a single EtOH withdrawal on δ-GABA~A~Rs were partially mimicked by PKC activation and blocked by PKC inhibition, we further investigated whether specific PKC isoforms were involved in these effects. Thirty-minute withdrawal from a single EtOH exposure increased PKCδ (*t* test; *t* = −2.678, *p* = 0.028; Figure [4A](#F4){ref-type="fig"}) but not PKCγ (Figure [4B](#F4){ref-type="fig"}) or PKCε level (Figure [4C](#F4){ref-type="fig"}) in hippocampal neurons, indicating that PKCδ may contribute to a single EtOH-withdrawal regulation of δ-GABA~A~Rs.

![A single EtOH withdrawal selectively increases total protein levels of PKCδ isoform in cultured neurons. **(A--C)** Representative western blots (top panels) and corresponding quantification (lower panels) of total protein levels of PKCδ **(A)**, PKCγ **(B)** and PKCε **(C)** isoforms in neurons from Ctrl and E/W groups, respectively. *n* = 4--5 per group. \**p* \< 0.05 (*t* test).](fnmol-11-00141-g0004){#F4}

To determine whether a single EtOH withdrawal-induced reduction in cell-surface protein level of δ subunits is specifically dependent on PKCδ activation, selective PKCδ inhibitor Rottlerin (Rot, 10 μM) and specific PKCδ siRNAs were both used. EtOH withdrawal in the presence of Rot (Rot+E/W) failed to induce any reduction in cell-surface level of δ subunits (one-way ANOVA; *F*~(3,18)~ = 8.173, *p* = 0.002; *p* = 0.003, E/W vs. Ctrl group; *p* = 0.608, Rot+E/W vs. Ctrl group; *p* = 0.015, Rot+E/W vs. E/W group), while Rot alone had no effect (*p* = 0.966, Rot vs. Ctrl group; *p* = 0.007, Rot vs. E/W group; Figure [5A](#F5){ref-type="fig"}). The PKCδ siRNAs reduced PKCδ levels by approximately 25% (PKCδ-siRNA1) and 60% (PKCδ-siRNA2), respectively, compared to vehicle-neurons (one-way ANOVA; *F*~(3,12)~ = 7.917, *p* = 0.004; *p* = 0.006, PKCδ-siRNA2 vs. vehicle group; *p* = 0.005; PKCδ-siRNA2 vs. Ctrl-siRNA group; Figure [5B](#F5){ref-type="fig"}). No significance was found between negative control siRNA (Crtl-siRNA) and vehicle groups. A single EtOH withdrawal induced a significant decrease in GABA~A~R-δ surface protein; in the condition of PKCδ-siRNA2, EtOH withdrawal did not induced significant effects (two-way ANOVA; *F*~(1,20)~ = 5.087, *p* = 0.035, PKCδ knockdown vs. Ctrl-siRNA groups; *F*~(1,20)~ = 10.246; *p* = 0.004, E/W vs. non-E/W group; *F*~(1,20)~ = 2.437; *p* = 0.048, significant interaction effect between groups and E/W treatments; Figure [5C](#F5){ref-type="fig"}), suggesting that EtOH withdrawal-induced reduction in cell-surface protein level of δ subunits depends on PKCδ activation. Besides, we also tested the roles of PKCε and PKCγ inhibition on EtOH withdrawal-induced reduction in GABA~A~R-δ abundance. PKCε inhibition by inhibitory peptide EAVSLKPT (EAV) in the presence of EtOH had no effect on EtOH withdrawal-induced reduction in cell-surface level of δ subunits (one-way ANOVA; *F*~(3,17)~ = 12.382, *p* = 0.001; *p* = 0.009, E/W vs. Ctrl group; *p* = 0.008, EAV+E/W vs. Ctrl group; *p* = 0.004, EAV vs. E/W group; *p* = 0.003, EAV vs. EAV+E/W group; Figure [5D](#F5){ref-type="fig"}). PKCγ inhibition by specific PKCγ siRNAs, which significantly reduced PKCγ levels (one-way ANOVA; *F*~(3,16)~ = 7.319, *p* = 0.003; *p* = 0.046, PKCγ-siRNA1 vs. vehicle group; *p* = 0.004, PKCγ-siRNA2 vs. vehicle group; *p* = 0.009, PKCγ-siRNA2 vs. Ctrl-siRNA group; Figure [5E](#F5){ref-type="fig"}), did not block the reduced cell-surface δ content (two-way ANOVA; *F*~(1,19)~ = 0.156, *p* = 0.698, PKCγ knockdown vs. Ctrl-siRNA groups; *F*~(1,19)~ = 23.422, *p* \< 0.001; Figure [5F](#F5){ref-type="fig"}). PKCδ inhibition by both Rot and PKCδ-siRNA2 prevented EtOH withdrawal-induced reduction in *I*~tonic~ amplitude and acute EtOH tolerance (two-way ANOVA; *F*~(5,140)~ = 80.767, *p* \< 0.001 vs. Ctrl group; *F*~(1,140)~ = 218.169, *p* \< 0.001 vs. the pre-EtOH baseline value; *F*~(5,140)~ = 7.620, *p* \< 0.001, significant interaction effect between groups and E/W treatments; Figures [6A,B](#F6){ref-type="fig"}), although a slight reduction in *I*~tonic~ potentiation by acute EtOH in PKCδ-siRNA2 group was observed (*p* = 0.013, PKCδ-siRNA2 vs. Ctrl group; Figures [6A,B](#F6){ref-type="fig"}). In addition, both Rot and PKCδ-siRNA2 blocked EtOH withdrawal-induced reduction in recombinant δ intensity (one-way ANOVA; *F*~(5,114)~ = 9.650, *p* \< 0.001; *p* \< 0.001, E/W vs. vehicle group; *p* \< 0.001, Rot+E/W vs. E/W group; *p* \< 0.001, PKCδ-siRNA2+E/W vs. E/W group; Figure [6C](#F6){ref-type="fig"}). Taken together, these data suggest that a single EtOH withdrawal modulates extrasynaptic δ-GABA~A~R function and protein level of δ subunits via PKCδ activation.

![PKCδ inhibition prevents the reduction in cell-surface GABA~A~R-δ level by a single EtOH withdrawal. **(A)** Representative western blots (top panels) and corresponding quantification (lower panel) of the biotinylation assay for cell-surface GABA~A~R-δ levels in neurons from Ctrl, E/W, PKCδ inhibitor rottlerin plus EtOH (Rot+E/W), and Rot alone treatments. **(B)** Representative western blots (top panels) and corresponding quantification (lower panel) of total protein levels of PKCδ isoform in neurons from vehicle, negative control siRNA (Ctrl-siRNA), PKCδ-siRNA1 and PKCδ-siRNA2 groups, respectively. **(C)** Representative western blots (top panels) and corresponding quantification (lower panel) of cell-surface GABA~A~R-δ levels in neurons from Ctrl-siRNA, PKCδ-siRNA2, Ctrl-siRNA+E/W, and PKCδ-siRNA2+E/W treatments, respectively.**(D)** Representative western blots (top panels) and corresponding quantification (lower panel) of cell-surface GABA~A~R-δ levels in neurons from Ctrl, E/W, PKCε inhibitor peptide EAVSLKPT plus EtOH (EAV +E/W) and EAV alone treatments, respectively. **(E)** Representative western blots (top panels) and corresponding quantification (lower panel) of total protein levels of PKCγ isoform in neurons from vehicle, Ctrl-siRNA, PKCγ-siRNA1 and PKCγ-siRNA2 groups, respectively. **(F)** Representative western blots (top panels) and corresponding quantification (lower panel) of cell-surface GABA~A~R-δ levels in neurons from Ctrl-siRNA, PKCγ-siRNA2, Ctrl-siRNA+E/W, and PKCγ-siRNA2+E/W treatments, respectively. *n* = 4--6 per group. \**p* \< 0.05, ^\*\*^*p* \< 0.01 (one-way ANOVA with *post hoc* Dunnett's test); ^\#^*p* \< 0.05, PKCδ knockdown vs. Ctrl-siRNA groups, ^†^*p* \< 0.01, E/W vs. non-E/W group (two-way ANOVA with *post hoc* Holm-Sidak test).](fnmol-11-00141-g0005){#F5}

![PKCδ inhibition prevents the reductions in extrasynaptic δ-GABA~A~R function and δ subunit level by a single EtOH withdrawal. **(A)** Sample traces of individual recordings in neurons from Ctrl, E/W, Rot+E/W and PKCδ-siRNA2+E/W treatments. **(B)** Changes in acute EtOH responsiveness in neurons from Ctrl, E/W, Rot, Rot+E/W, PKCδ-siRNA2, and PKCδ-siRNA2+E/W treatments, respectively. *n* = 10--14 per group. **(C)** Representative time-lapse live-cell images of pcDNA3.1-GABA~A~R-δ-mCherry transfected-neurons from E/W, Rot+E/W and PKCδ-siRNA2+E/W treatments (left panels) and changes in recombinant δ subunit intensity in transfected-neurons from vehicle, E/W, Rot, Rot+E/W, PKCδ-siRNA2, and PKCδ-siRNA2+E/W treatments, respectively (right panel). Scale bar = 10 μm. *n* = 20 per group. ^†^*p* \< 0.001 vs. the pre-EtOH baseline value (black ^†^, Ctrl; gray ^†^, Rot; green ^†^, Rot+E/W; cyan ^†^, PKCδ-siRNA2; purple ^†^, PKCδ-siRNA2+E/W), \**p* \< 0.001 vs. Ctrl group (cyan \*, PKCδ-siRNA2; orange \*, E/W; two-way ANOVA with *post hoc* Holm-Sidak test); ^\#^*p* \< 0.001, E/W vs. vehicle group, Rot+E/W vs. E/W group, or PKCδ-siRNA2+E/W vs. E/W group (one-way ANOVA with *post hoc* Dunnett's test).](fnmol-11-00141-g0006){#F6}

Discussion {#s4}
==========

The profound rapid reductions in extrasynaptic δ-GABA~A~R-mediated function and protein level of δ subunits in hippocampal neurons induced by a single EtOH withdrawal suggest that PKCδ plays an important role in the alteration of sensitivity to EtOH. Such alterations can be partially mimicked by a phosphotase inhibitor (OA) and a PKC activator (PDBu) exposure but was successfully blocked by the general PKC inhibitor (Che), selective PKCδ inhibitor (Rot) and specific PKCδ siRNAs. The findings provide direct evidence that a single EtOH withdrawal rapidly regulates extrasynaptic δ-GABA~A~Rs via PKCδ activation.

Previous studies have reported that the rat model of CIE and withdrawal simulates the symptoms of EtOH dependence and EtOH withdrawal in humans, including reduced seizure threshold and enhanced seizure susceptibility that related to GABA~A~R alterations (Olsen and Spigelman, [@B43]). GABA~A~R subunit composition, function, and sensitivity to EtOH and benzodiazepines are altered in CIE-rats, accompanied by behavior abnormalities (Liang et al., [@B32]). A single intoxicating EtOH exposure could induce similar but temporary GABA~A~R changes (known as GABA~A~R plasticity) *in vivo* (Liang et al., [@B31]), while a single EtOH withdrawal leads to similar alterations *in vitro* (Shen et al., [@B50]). A single EtOH exposure triggers a short and small withdrawal response (mini-withdrawal) at every EtOH intake, and the single "mini-withdrawal" results in GABA~A~R plastic changes. Chronic EtOH exposure may further induce repeated "mini-withdrawals" to keep the brain in a continuous state of withdrawal, resulting in irreversible and permanent pathological changes from temporary GABA~A~R plasticity (Liang et al., [@B31]; Olsen and Spigelman, [@B43]; Olsen and Liang, [@B41]). Importantly, in addition to the remarkable GABA~A~R plasticity, the animals with a single intoxicating dose of EtOH exhibit tolerance to benzodiazepine- and high dose EtOH-induced loss of righting reflex (LORR; Liang et al., [@B31]). Therefore, it suggests that a single EtOH withdrawal-regulation of GABA~A~Rs may be the basis for chronic EtOH tolerance and alcohol withdrawal syndromes (AWS; Olsen and Liang, [@B41]).

Tonic inhibitory currents are mediated by extrasynaptic GABA~A~Rs, activated by \~0.2--2.0 μM ambient or "spillover" extracellular GABA (Mody and Pearce, [@B37]; Semyanov et al., [@B49]; Farrant and Nusser, [@B16]). Tonic inhibition is mediated primarily by α5βγ2-GABA~A~Rs in the hippocampal CA1 region (Caraiscos et al., [@B9]; Mangan et al., [@B33]) and by α4βδ-GABA~A~Rs in the dentate gyrus (Laurie et al., [@B29]; Sperk et al., [@B52]; Peng et al., [@B44]; Liang et al., [@B32]). Tonic inhibition is thought to play a more important role in controlling neuronal excitability rather than phasic inhibition (Mody and Pearce, [@B37]). The rapid (within 1-h withdrawal) internalization of extrasynaptic δ-GABA~A~Rs by a single EtOH exposure and withdrawal occurs in both the rat model and cultured neurons (Liang et al., [@B31]; Shen et al., [@B50]), leading to a rapid drop of *I*~tonic~ and acute EtOH tolerance. In comparison, synaptic α1-GABA~A~R internalization occurs at 4-h withdrawal, resulting in delayed decreases in synaptic inhibition and cross-tolerance to benzodiazepines (Shen et al., [@B50]). This demonstrates that extrasynaptic δ-GABA~A~Rs could be initial responders to a single EtOH withdrawal (Gonzalez et al., [@B18]). In our study, we observed a rapid reduction of *I*~tonic~ amplitude and acute EtOH tolerance by 30-min EtOH withdrawal, which were paralleled with the decreased protein level of δ subunits. Neither area nor frequency of mIPSCs was affected by EtOH withdrawal, consistent with unaltered protein level of α1 subunits. The results are similar to the findings reported previously (Shen et al., [@B50]). By contrast, 30-min EtOH exposure increased the baseline tonic activity with no effect on the protein level of δ subunits, similar as the effects found in acute EtOH (60 mM) application (Liang et al., [@B31]; Shen et al., [@B50]; Carlson et al., [@B11]), indicating that 60 mM EtOH exposure for 30 min acts as acute EtOH challenge in our system. Although the exactly mechanism has yet to be clarified, it is possible that withdrawal from an intoxicating, acute EtOH exposure may accelerate EtOH regulation of extrasynaptic GABA~A~Rs in cultures *in vitro*. Additionally, a decrease in protein level of recombinant δ but not α1 subunits was also observed, supporting that 30-min EtOH withdrawal specifically down-regulated the protein level of GABA~A~R-δ subunits. The differences in timing of changes in extrasynaptic and synaptic GABA~A~Rs suggest the distinct mechanisms of responsiveness to EtOH, possibly due to the highly preferential sensitivity of extrasynaptic δ-GABA~A~Rs to EtOH (Sundstrom-Poromaa et al., [@B53]; Wallner et al., [@B54]). Besides, our prior work (Shen et al., [@B50]) shows that α5βγ2-GABA~A~R-mediated tonic currents are also affected by EtOH, with slightly delayed α5 internalization (does not occur at 20-min withdrawal, whereas α4 and δ do). These data suggest that α5βγ2-GABA~A~Rs are downstream, but not the initial responders from EtOH activation. Although we cannot rule out the contribution of α5βγ2-GABA~A~Rs to tonic inhibition in the current study, it is likely that α5βγ2-GABA~A~R alterations by EtOH may have a different mechanism of regulation.

In our cultures, 30-min OA exposure partially mimicked the effects of a single EtOH withdrawal on *I*~tonic~ amplitude and acute EtOH sensitivity, suggesting the important roles of protein phosphorylation in a single EtOH withdrawal-regulation of extrasynaptic δ-GABA~A~Rs. This is consistent with previous evidence that protein phosphorylation is crucial for EtOH regulation of both synaptic and extrasynaptic receptors (Qi et al., [@B47]; Choi et al., [@B14]; Jacob et al., [@B23]; Nakamura et al., [@B38]). PKC has been shown to play important roles in EtOH regulation of GABA~A~Rs. Our results showed that PKC inhibition prevented EtOH withdrawal-induced *I*~tonic~ reduction and acute EtOH tolerance as well as the reduced protein level of GABA~A~R-δ subunits, indicating that PKC activation contributes to a single EtOH withdrawal-regulation of extrasynaptic δ-GABA~A~Rs. These results are supported by the previous study showing that PKC activation causes down-regulation of tonic GABA~A~R-mediated inhibition in dentate gyrus granule cells in the hippocampus and dorsal lateral geniculate relay neurons in the thalamus (Bright and Smart, [@B7]). Furthermore, 30-min EtOH withdrawal selectively increased total protein level of PKCδ in cultures, which is not surprising since previous studies report that EtOH exposure alters the subcellular localization of PKCδ in neuronal cells (Messing et al., [@B35]; Gordon et al., [@B19]). Meanwhile, PKCδ inhibition specifically blocked the reductions in protein levels of both native and recombinant δ subunits, as well as acute EtOH tolerance. The data indicate that the rapid regulation of extrasynaptic δ-GABA~A~Rs by a single EtOH withdrawal is most likely mediated via PKCδ activation. However, the present results are not consistent with previous studies showing that EtOH enhancement of α4β3δ-GABA~A~R function is PKCδ-dependent (Choi et al., [@B14]) and PKC activity regulates α4-GABA~A~R membrane insertion by phosphorylation of the α4 subunits (Abramian et al., [@B2]). Although we do not know whether the differences in expression systems (neurons vs. non-neuron cell lines) or EtOH treatments (a single intoxicating EtOH withdrawal vs. acute EtOH response or non-EtOH application), both may contribute to the discrepant results. Besides, PKCβ, PKCγ and PKCε levels in cultured cortical neurons are also altered by EtOH exposure in a previous study (Kumar et al., [@B28]), however, no alteration in either PKCγ or PKCε level was observed in hippocampal neurons with a single EtOH withdrawal in our experiment. We postulate that it may be due to the different neuron types and EtOH treatment procedures.

PKA inhibition did not prevent either EtOH withdrawal-induced *I*~tonic~ reduction or acute EtOH tolerance, while PKA activation also had no effect on extrasynaptic δ-GABA~A~R function in our study. The data are not consistent with previous studies showing the major roles of PKA in EtOH regulation of extrasynaptic α4-GABA~A~R function and subunit expression both *in vivo* (Carlson et al., [@B12]) and *in vitro* (Carlson et al., [@B10],[@B11]), since there are paralleled changes in protein levels of α4 and δ subunits as well as α4δ-GABA~A~R function induced by EtOH withdrawal in neurons (Shen et al., [@B50]). Although we cannot rule out the possibility that short application (30 min) of forskolin alone may not have been long enough to detect changes in responding or may require EtOH activation synchronously, our present data suggest that PKA activation may not play a role in the condition of a single intoxicating EtOH withdrawal but not prolonged EtOH exposure (1--4 h) in previous studies (Carlson et al., [@B10],[@B11]).

Clathrin-dependent endocytosis is one of the major internalization mechanisms for neuronal GABA~A~Rs (Kittler et al., [@B25]). The clathrin adaptor protein 2 (AP2) complex plays a critical role in recruiting membrane associated proteins into clathrin-coated pits. Phosphorylation of GABA~A~R subunits at distinct AP2 binding sites can regulate the cell surface stability of GABA~A~Rs, the strength of synaptic inhibition (Jacob et al., [@B23]) and tonic inhibition (Kumar et al., [@B26]). Differential regulation of GABA~A~R subunits by phosphorylation may be one of the key factors contribute to the discrepant EtOH regulation of GABA~A~R function and expression. One previous study demonstrates that EtOH promotes AP2-mediated endocytosis via the intracellular domain of δ-GABA~A~Rs (δ-ICD; Gonzalez et al., [@B18]). However, neither the changes in β2/3 association with AP2 machinery caused by phosphorylation nor α4 phosphorylation is responsible for the endocytosis, since the dephosphorylation of β3 and γ2 subunits promotes internalization of synaptic GABA~A~Rs (Kittler et al., [@B24]) whereas α4 phosphorylation dictates insertion into the membrane (Abramian et al., [@B2]). The final possibility for the rapid endocytosis of δ-GABA~A~Rs is the primary interactions involving the δ subunits, as EtOH increases the affinity between δ-ICD and AP2-μ2 (Gonzalez et al., [@B18]). The rapid down-regulation of extrasynaptic δ-GABA~A~Rs by a single EtOH withdrawal in present study is likely triggered by the increased interaction between δ-ICD and AP2-μ2 via PKCδ-mediated phosphorylation of μ2 regions in δ subunits. One previous study suggests a phosphorylation regulation of GABA~A~R-α4 subunits in the thalamus by PKCγ and PKCδ isoforms (Werner et al., [@B58]), however, it is unclear whether δ-ICD can be directly phosphorylated by PKCδ or other PKC isoforms. It would be important to test the functional significance of these μ2 binding sites within the ICD, as they potentially regulate the cell surface number of δ-GABA~A~Rs (Gonzalez et al., [@B18]). Future studies are required to clarify the mechanisms of a single EtOH withdrawal-regulation of δ-GABA~A~Rs via phosphorylation by PKCδ or other PKC isoforms.

In conclusion, the current work demonstrates a crucial role for PKCδ in the rapid regulation of extrasynaptic δ-GABA~A~R function and protein level by a single EtOH withdrawal. In view of the hypothesis that extrasynaptic δ-GABA~A~R endocytosis is the possible trigger for EtOH-induced GABA~A~R plasticity, PKCδ-mediated protein phosphorylation is potentially an important mechanism underlying EtOH withdrawal-regulation of GABA~A~Rs. Therefore, selective targeting of PKC isoforms may serve as potentially therapeutic approaches that aim to restore normal GABA~A~R function and subunit abundance altered by EtOH exposure and withdrawal.
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ACSF

:   artificial cerebral spinal fluid

AWS

:   alcohol withdrawal syndrome

CIE

:   chronic intermittent ethanol

DIV

:   days *in vitro*

DMSO

:   dimethyl sulfoxide

E18

:   embryonic day 18

EAV

:   EAVSLKPT

EtOH

:   ethanol

GABA

:   γ-aminobutyric acid

GABA~A~Rs

:   GABA~A~ receptors

H89

:   H-89 dihydrochloride hydrate

HBSS

:   Hank's balanced salt solution

HEPES

:   N-2-hydroxy-ethylpiperazine-N-2-ethanesulfonic acid

HRP

:   horseradish peroxidase

*I*~tonic~

:   tonic current

mIPSC

:   miniature inhibitory postsynaptic current

P/S

:   penicillin/streptomycin

PAGE

:   polyacrylamide gel electrophoresis

PBS

:   phosphate-buffered saline

PDBu

:   phorbol 12,13-dibutyrate

PDL

:   poly-D-lysine

PKA

:   protein kinase A

PKC

:   protein kinase C

PVDF

:   polyvinylidene fluoride

SDS

:   sodium dodecyl sulfate

TBS

:   Tris-buffered saline.
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